Trials / Completed
CompletedNCT04913402
Sufentanil Used by Paramedics to Treat Pain in Acute Trauma
The Safety of Administration of Sufentanil by Paramedics to Treat Pain in Acute Trauma in The Prehospital Setting: Observational Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 158 (actual)
- Sponsor
- Zdravotnicka Zachranna Sluzba Karlovarskeho Kraje, P.O. · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The new competence of paramedics to administer opioid analgesics in acute trauma patients without presence or phone-call consult with an emergency medical doctor will be assessed in this study.
Detailed description
The administration and indication of an opioid analgesics is carried by a medical doctor in most European emergency services. However, trips to majority of less serious traumas are realized by ambulances with paramedic crews without a medical doctor present on site. In this study will be assessed the new competence of paramedics to administer opioid analgesics without presence or phone-call consult with an emergency medical doctor. This study will address the safety and efficacy of sufentanil administered by the paramedics in the field to patients with acute trauma without any consultation with medical doctors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Sufentanil administered by paramedics after the phone call consultation of medical doctor. | Administration of sufentanil to patients with acute injury by paramedics only after phone-call consultation of medical doctor. |
| OTHER | Sufentanil administered by paramedics based on their competency, without consultation of medical doctor. | Administration of sufentanil to patients with acute injury by paramedics with competency to administer sufentanil without medical doctor consultation. |
Timeline
- Start date
- 2020-09-14
- Primary completion
- 2021-03-23
- Completion
- 2021-05-15
- First posted
- 2021-06-04
- Last updated
- 2021-06-04
Locations
1 site across 1 country: Czechia
Source: ClinicalTrials.gov record NCT04913402. Inclusion in this directory is not an endorsement.